Part,  Chapter, Paragraph

 1   II,     5.  5.  3|       system, characterised by inflammation, demyelination and primary
 2   II,     5.  5.  3|   central nervous system (CNS) inflammation compared to placebo.~Five
 3   II,     5.  6.  3|      variable degrees of local inflammation.~ ~Case definition can be
 4   II,     5.  8.  7|     Scott S. (2006): Is Airway Inflammation in Chronic Obstructive Pulmonary
 5   II,     5.  8.  7|          Differences in airway inflammation in patients with fixed airflow
 6   II,     5.  9.  4|       in vitro, on respiratory inflammation in vivo, and on adjuvant
 7   II,     5.  9.  4|    well correlated. Markers of inflammation in the in vitro and in vivo
 8   II,     5.  9.  4|        and between allergy and inflammation markers was generally poor.
 9   II,     5.  9.  4|   associated with measures for inflammation and acute toxicity. The
10   II,     5. 11.  3| hyper-proliferation and dermal inflammation. The extent and duration
11   II,     6.  3.  5|       is an acute disease with inflammation of the mucosal surfaces
12  III,    10.  2.  1|        toothbrushing. Gingival inflammation is a necessary but not sufficient
13  III,    10.  2.  1|       5-6% of gum sites showed inflammation. In the UK, only about a
14  III,    10.  2.  1|    five-year-olds had gingival inflammation compared to almost two thirds (
15  III,    10.  2.  1|        year-olds have gingival inflammation indicates that plaque control
16  III,    10.  3.  3|       is an acute disease with inflammation of the mucosal surfaces
17  Key,   Ap5.  0.  0| infants~infarction~infertility~inflammation~influenza~influenzae~inhalation~